St. Jude Children’s Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Then researchers identified safety concerns with the experimental drug that have implications for current clinical trials in adults. The study appears today in Nature Communications.
Safety concerns raised for neuroblastoma candidate drug
November 9, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022